Archives for February 4, 2005

← 2005

Excipient industry calls for Euro master file system

The pharmaceutical excipients industry urgently needs a system of European master files, already used by the active pharmaceutical ingredient sector (API), to stimulate innovation in the sector and bring Europe's regulatory stance in line with the US....

Researchers target Alzheimer's enzyme

Significant progress toward a more targeted treatment of Alzheimer's disease was made as scientists targeted an enzyme, which has a differentiated role and opens up perspectives for new drugs that have fewer undesired side effects.

Hana initiates trials of PT-523 for lung cancer

Hana Biosciences announced today the clinical trial initiation of PT-523 to evaluate this compound as a single agent in relapsed non-small cell lung cancer (NSCLC). Lung cancer continues to carry the poorest prognosis of cancer, with a five-year...

Next-gen renin inhibitor results encouraging

Speedel Experimenta has announced the completion of its human micro-dosing studies into renin inhibitors that are set to provide an effective means of treating hypertension and for protecting end organs such as the heart and kidneys.

Qiagen launches siRNA design service

Qiagen launches a unique siRNA design service that provides a guarantee that at least 50 per cent of the siRNAs produced will result in efficient knockdown to the researcher's specific requirements.

BASF backs novel encapsulation technology

Chemicals giant BASF has invested €2 million in a small German encapsulation business that claims to have developed a novel process that allows for efficient ingredient delivery.